William E. Rote, SVP, R&d: Travere Therapeutics TVTX Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $47,424.02
Shares · price: 2,437 sh · $19.46 a share
Held after: 83,170 sh
Stock: Travere Therapeutics TVTX
Person: William E. RoteSVP, R&d
Trade date: 25/01/22
Filed: 25/01/23
Days to filing: 1 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/23~25/02/21

William E. Rote's recent trades

William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$7.1M
112,850 sh
$7.1M
Filed 09/16
Traded 09/16
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
96,198 sh
$6.3M
Filed 09/15
Traded 09/15
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$355.7K
9,100 sh
$355.7K
Filed 04/23
Traded 04/22